CVS Health Corp. is beginning human trials of a new home dialysis machine that could shake up the $35 billion market for end-stage kidney care and create a new business for the drugstore chain. The ...
The pandemic has many of us relying on technology in new ways. And it prompted some innovation, including in the health care sector. For example, patients who need dialysis on a regular basis mostly ...